Applications of Nanosized-Lipid-Based Drug Delivery Systems in Wound Care
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Impaired wound healing is an encumbering public health issue that increases the demand for developing new therapies in order to minimize health costs and enhance treatment efficacy. Available conventional therapies are still unable to maximize their potential in penetrating the skin at the target site and accelerating the healing process. Nanotechnology exhibits an excellent opportunity to enrich currently available medical treatments, enhance standard care and manage wounds. It is a promising approach, able to address issues such as the permeability and bioavailability of drugs with reduced stability or low water solubility. This paper focuses on nanosized-lipid-based drug delivery systems, describing their numerous applications in managing skin wounds. We also highlight the relationship between the physicochemical characteristics of nanosized, lipid-based drug delivery systems and their impact on the wound-healing process. Different types of nanosized-lipid-based drug delivery systems, such as vesicular systems and lipid nanoparticles, demonstrated better applicability and enhanced skin penetration in wound healing therapy compared with conventional treatments. Moreover, an improved chemically and physically stable drug delivery system, with increased drug loading capacity and enhanced bioavailability, has been shown in drugs encapsulated in lipid nanoparticles. Their applications in wound care show potential for overcoming impediments, such as the inadequate bioavailability of active agents with low solubility. Future research in nanosized-lipid-based drug delivery systems will allow the achievement of increased bioavailability and better control of drug release, providing the clinician with more effective therapies for wound care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gurtner, G. C., Werner, S., Barrandon, Y., & Longaker, M. T. (2008) · Nature · doi:10.1038/nature07039 · Cited by 6,542
Wound repair and regeneration: Mechanisms, signaling, and translation
Eming, S. A., Martin, P., & Tomic-Canic, M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009337 · Cited by 3,562 · cited 1×
“Patients with risk factors such as smoking, diabetes mellitus, sickle cell disease, vascular insufficiency, atherosclerotic disease, local pressure effects and immunological factors are predisposed to abnormal healing, which leads to chronic wounds [10,16,17].”
BackgroundHuman skin wounds: A major and snowballing threat to public health and the economy
Sen, C. K., Gordillo, G. M., Roy, S., Kirsner, R., Lambert, L., Hunt, T. K., Gottrup, F., Gurtner, G. C., & Longaker, M. T. (2009) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2009.00543.x · Cited by 2,965
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Menke, N. B., Ward, K. R., Witten, T. M., Bonchev, D. G., & Diegelmann, R. F. (2007) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2006.12.005 · Cited by 792
Ellis, S., Lin, E. J., & Tartar, D. (2018) · Current Dermatology Reports · doi:10.1007/s13671-018-0234-9 · Cited by 625 · cited 1×
“It involves activation of the immune system’s cellular components, the coagulation cascade, and the inflammatory pathways, leading to a massive remodeling of all skin compartments [1,2].”
BackgroundA brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems
Duan, Y., Dhar, A., Patel, C., Khimani, M., Neogi, S., Sharma, P., Siva Kumar, N., & Vekariya, R. L. (2020) · RSC Advances · doi:10.1039/d0ra03491f · Cited by 614 · cited 1×
“A growing interest has been directed toward lipid nanoparticles [39] which, based on recent findings, are superior to vesicular systems, as they exhibit better penetration into the deeper layers of the epidermis [32].”
BackgroundGuest Editorial: are diabetes‐related wounds and amputations worse than cancer?
Armstrong, D. G., Wrobel, J., & Robbins, J. M. (2007) · International Wound Journal · doi:10.1111/j.1742-481x.2007.00392.x · Cited by 456
Nanoparticles skin absorption: New aspects for a safety profile evaluation
Larese Filon, F., Mauro, M., Adami, G., Bovenzi, M., & Crosera, M. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.05.005 · Cited by 390
MicroRNA-132 enhances transition from inflammation to proliferation during wound healing
Li, D., Wang, A., Liu, X., Meisgen, F., Grünler, J., Botusan, I. R., Narayanan, S., Erikci, E., Li, X., Blomqvist, L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79052 · Cited by 231
Manca, M. L., Matricardi, P., Cencetti, C., Peris, J. E., Melis, V., Carbone, C., Escribano, E., Zaru, M., Fadda, A. M., & Manconi, M. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.008 · Cited by 134
Skin endometriosis: A case report and review of the literature
Matei, A.-M., Draghici‑Ionescu, A.-M., Cioplea, M., Zurac, S., Boda, D., Serban, I., Caruntu, C., Ilie, M., & Gyula, L. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9964 · Cited by 16
Self-citation
Cited by
Paclitaxel: Application in Modern Oncology and Nanomedicine‐Based Cancer Therapy
Sharifi-Rad, J., Quispe, C., Patra, J. K., Singh, Y. D., Panda, M. K., Das, G., Adetunji, C. O., Michael, O. S., Sytar, O., Polito, L., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3687700 · Cited by 298
Self-citationMyricetin: Targeting signaling networks in cancer and its implication in chemotherapy
Javed, Z., Khan, K., Herrera-Bravo, J., Naeem, S., Iqbal, M. J., Raza, Q., Sadia, H., Raza, S., Bhinder, M., Calina, D., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02663-2 · Cited by 93
“Nanoformulation is carried out in numerous ways owing to a wide range of shapes and forms of nanoscale particles [19, 63].”
BackgroundTherapeutic Applications of Curcumin in Diabetes: A Review and Perspective
Quispe, C., Herrera-Bravo, J., Javed, Z., Khan, K., Raza, S., Gulsunoglu-Konuskan, Z., Daştan, S. D., Sytar, O., Martorell, M., Sharifi-Rad, J., et al. (2022) · BioMed Research International · doi:10.1155/2022/1375892 · Cited by 92
Therapeutic applications of curcumin nanomedicine formulations in cystic fibrosis
Quispe, C., Herrera-Bravo, J., Khan, K., Javed, Z., Semwal, P., Painuli, S., Kamiloglu, S., Martorell, M., Calina, D., & Sharifi-Rad, J. (2022) · Progress in Biomaterials · doi:10.1007/s40204-022-00198-3 · Cited by 26
Metadata
- Authors
- Matei, A.-M., Caruntu, C., Tampa, M., Georgescu, S. R., Matei, C., Constantin, M. M., Constantin, T. V., Calina, D., Ciubotaru, D. A., Badarau, I. A., Scheau, C., & Caruntu, A.
- Venue
- Applied Sciences
- Publisher
- MDPI AG
- Published
- 2021-05-27
- Volume
- 11
- Issue
- 11
- Pages
- 4915
- ISSN
- 2076-3417 (ISSN-L)
- OpenAlex
- W3168777948
- Cited by
- 93
- References
- 12
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.